NCT05309902View on ClinicalTrials.gov

A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 11, 2022

Primary Completion Date

December 6, 2022

Study Completion Date

December 6, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Soticlestat

Soticlestat tablet.

DRUG

Placebo

Soticlestat placebo-matching tablet.

DRUG

Moxifloxacin

Moxifloxacin over-encapsulated tablet.

DRUG

Placebo

Moxifloxacin placebo-matching capsule.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY